Mecasermin
From Wikipedia, the free encyclopedia
This article does not cite any references or sources. (April 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
Mecasermin
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | ? |
Mol. mass | ? |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status | |
Routes | Subcutaneous |
Mecasermin, also known as mecasermin rinfabate (brand names Increlex and Iplex) is a growth hormone which is used for the long-term treatment of growth failure in children with severe primary IGF-1 deficiency.
|